Litfulo TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: ritlecitinib
Brand name
(ARTG)
: LITFULO ritlecitinib (as tosylate) 50 mg hard capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
LITFULO is indicated for the treatment of severe alopecia areata (AA) in adults and adolescents 12 years of age and older (see Section 5.1 Pharmacodynamic properties)
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule, hard
- Oral
- Opaque hard capsule, yellow body/blue cap, body printed with RCB 50 and the cap is printed with Pfizer
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Protect from Light
- Store in Original Container
- Shelf lifetime is 30 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 10 capsules (starter pack) pack
- 30 capsules pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ritlecitinib
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
